This invention relates to the transalkoxylation of nucleophilic compounds, especially the transoxylation of compounds having heteroatoms.
The preparation of alkoxylated compounds is well known. Typically, the method used to prepare alkoxylated compounds produces a mixture of products that is less than ideal. This is especially in the case in the preparation of alkoxylated, nitrogen compounds such as alkanolamines.
For example, alkanolamines, such as monoethanolamine (MEA), diethanolamine (DEA), and triethanolamine (TEA) are often prepared by reacting ethylene oxide with ammonia. The resulting product is a mixture of MEA, DEA, and TEA. While changing the stoichiometry of the reactants can vary the ratio of these amines in the final product mixture, the reaction is still not sufficiently selective to produce a high level of DEA.
Various approaches have been used to overcome this problem. For example, U.S. Pat. No. 4,264,776 (to Monsanto), Apr. 28, 1981, discloses the catalytic oxidation of tertiary amines with oxygen to form secondary amines in the presence of an active carbon catalyst. An example is provided which treats TEA over active carbon at 115° C. in the presence of oxygen with 60% conversion to DEA.
U.S. Pat. No. 4,328,370 (to TDCC), May 4, 1982, discloses the use of hydrogenation catalysts (Pd, Pt, Rh, Ru) at super-atmospheric pressure under anhydrous conditions. For example, TEA is treated with ammonia in the presence of Pd/C or Pd/Al2O3, optionally in the presence of hydrogen, at 200-300° C. to give MEA and DEA.
U.S. Pat. No. 6,469,214 B2 (to BASF) Oct. 22, 2002, discloses the preparation of DEA from a mixture of MEA and TEA in the presence of a strong base and, optionally, ammonia. The preferred strong bases are alkali metal and alkaline earth metal hydroxides, or an alkali metal alkoxide.
WO 2007/093514 A1 (to BASF), Aug. 23, 2007, discloses the conversion of monoethylene glycol into MEA and DEA via a reductive amination.
U.S. Pat. No. 6,169,207 (to Nippon Shokubai Kagaku Kogyo (NSKK)), 2001, discloses selective ethoxylation.
There remains a need for a more efficient method for the preparation of, for example, secondary alkanolamines.
The present invention provides a method for the transalkoxylation of nucleophilic compounds in which a hydroxyalkyl group on a heteroatom of one compound is transferred to another compound. The method can be practiced with or without the use of additional nucleophiles.
In one embodiment, the present invention provides a method of transferring a hydroxyalkyl group from an alkoxyated compound to a nucleophilic compound comprising the steps of
In another embodiment, the present invention provides a method of transalkoxylating an alkoxylated compound comprising the steps of:
In yet another embodiment, the present invention provides a method of transalkoxylating an alkanolamine compound comprising the steps of:
In a further embodiment of the invention, the first and second alkanolamines are selected from (i) a primary and a tertiary alkanolamine, or (ii) a secondary and a tertiary alkanol amine, or (iii) a primary and a secondary alkanolamine.
In the present invention, the transfer of the hydroxyaklyl group is preferably from the compound that has the greater degree of substitution to the compound that has the lesser degree of substitution.
The method of the present invention provides several advantages over the prior art. For example, it eliminates the need to employ strong bases and therefore avoids the problems associated with salt formation during the process. Additionally, it provides a mechanism by which desired alkanolamines, especially DEA, may be produced with high selectivity.
Additionally, the method of the invention is economical in that it can be used with conventional equipment. Furthermore, the present invention employs non-precious metal catalysts, thereby eliminating the need for the use of such materials.
The materials required in the process of the invention include an alkoxylated compound, a nucleophile and a heterogeneous catalyst. The alkoxylated compound may be any heteroatom-containing compound in which the heteroatom is substituted with a hydroxyalkyl group. Preferably, the heteroatom is nitrogen (also referred to herein by its chemical symbol “N”). The most preferred alkoxylated compound for use in the present invention is an alkanolamine that may be represented the formula
(R1)(R2)(R3)N
wherein R1 is a hydroxyalkyl group having from 2-20 carbon atoms, and each of R2, and R3 group is independently selected from hydrogen, alkyl groups having from 1 to 20 carbon atoms, and hydroxyalkyl groups having from 2-20 carbon atoms. Preferably, each of R1, R2, and R3 contain from 1-5 carbon atoms, and more preferably from 1-3 carbon atoms. A preferred subclass of alkanolamines for use in the present invention is selected from one or more of MEA, DEA, and TEA.
Any nucleophilic compound may be employed in the process of the present invention. The nucleophilic compound is preferably selected from one or more of an alkanolamine of the formula (R1)(R2)(R3)N, wherein R1, R2, and R3 are as defined above in all respects, an alkyleneamine, an alkylamine, water and an alcohol. The alkylene and alkyl groups of the alkyleneamine and alkylamine compounds preferable contain from 1-20 carbon atoms. Preferably, the nucleophilic compound comprises an alkanolamine compound. A preferred subclass of alkanolamines for use as the nucleophilic compound in the present invention is selected from one or more of MEA, DEA, and TEA.
The catalyst used in the present invention may be any heterogeneous catalyst. Preferably the catalyst is not a hydrogenation catalyst. Also the catalyst used in the present invention is preferably not a precious metal catalyst.
A particularly preferred catalyst for use in the present invention is zirconium dioxide (ZrO2), also sometimes referred to as zirconia. Zirconia is a slightly acidic metal oxide compound. Zirconia useful in the present invention may have any surface area. Typically it has a surface area of from about 40-100 m2/g. Preferably the zirconia has a surface area of from about 50-90 m2/g, and more preferably of from about 50-75 m2/g.
The catalyst may also include other materials that enhance the performance of the method of the invention. While the mechanism of the enhancement is not fully understood, it has been found that when certain additives are used in combination with the heterogeneous catalyst the formation of certain impurities is suppressed. These additives include metal oxides that may be oxides of the Group IA, the Group IIA, the Lanthanide series, and the Actinide series of the Periodic Table of the Elements. Preferably the additives are selected from oxides of sodium, potassium, cesium, magnesium, and calcium. The additive generally comprises from about 0.5-15% by weight of the catalyst. Preferably it comprises from about 1-10% by weight, and more preferably from about 1-5% by weight, of the catalyst.
The method of the invention will now be discussed with respect to the transalkoxylation of alkanolamines. Specifically, the method will be discussed with respect to the transethoxylation of MEA by TEA to produce DEA. It is to be understood that this is not intended to limit the present invention, but rather to facilitate the discussion and understanding of the present invention.
The transethoxylation of MEA by TEA to produce DEA may be represented by the general scheme
In the process, a feed of an alkoxylated compound (here TEA) and a nucleophilic compound (here MEA) is provided to a suitable reactor. One of the compounds has a higher degree of substitution than the other of the compounds. When the feed comprises two alkanolamines, it preferably comprises one of (i) a primary and a tertiary alkanolamine, (ii) a secondary and a tertiary alkanol amine, or (iii) a primary and a secondary alkanolamine.
Typically, the compounds of the feed are dissolved in a suitable solvent prior to being fed to the reactor. Suitable solvents include ethers, acetonitrile, methanol, ethylene glycol, and water.
The compounds may be dissolved in the solvent at a molar ratio of from about 10:1 to about 1:10 of the alkoxylated compound to the nucleophilic compound, preferably at a ratio of from about 5:1 to about 1:5, and more preferably at a ratio of from about 2:1 to about 1:2. The solution typically comprises from about 1% to about 100% by weight of the reactants. Preferably it comprises from about 5% to about 50% by weight of the reactants. More preferably it comprises from about 10% to about 30% by weight of the reactants.
Once dissolved, the reactants may be fed to a reactor, such as a tubular reactor, and passed over the catalyst. The reaction may be carried out in an inert atmosphere. Alternatively, it may be carried out in an oxygen-containing atmosphere. In either event, the reaction is carried out in an atmosphere that does not adversely affect it. Preferably, the reaction is carried out by simultaneously feeding the dissolved reactants and the gas to the reactor. Suitable gasses include nitrogen alone, or nitrogen with up to 25% by volume of oxygen. Preferably the gas is selected from nitrogen and nitrogen with from about 1-10% (more preferably from 3-5%) by volume oxygen.
The flow rates of the reactants and the gas are adjusted so that the reactants held in the reactor for a time and under conditions capable of transferring at least one hydroxyalkyl group from the more substituted compound to the less substituted compound. While these conditions can be varied to suit the individual reactions, they typically comprise the following:
Hourly Liquid Space Velocity of Reactant Solution (HLSV):
Hourly Gas Space Velocity of Gas (HGSV):
Reaction Temperature:
The pressure at which the reaction is carried out is not critical to the invention. It may be carried out under vacuum or at super atmospheric pressure. Preferably it is carried out at atmospheric pressure.
In some embodiments, the most preferable operating conditions are:
General Procedure. Approximately 3 g of catalyst was charged to a ⅜″ O.D. 304 SS tube that was placed in a microfurnace at atmospheric pressure. A 1:1 mol ratio of MEA and TEA was dissolved in water to make a 30 wt % solution and this was fed over the catalyst at the following conditions:
The reaction products were collected neat in a glass container packed with wet ice. The concentration of DEA manufactured was determined using gas chromotography and reported as area percent of product.
The above general procedure was followed using medium surface area zirconia (72 m2/g). In one experiment, the gas feed was nitrogen, and in another the gas feed contained 5% oxygen. The results of these reactions are given in Table 1.
The general procedure was repeated with the O2/N2 feed as in Example 1, except that various metal oxide additives were incorporated into the zirconia catalyst (72 m2/g surface area). These additives reduced the amount of the major by-product, hydroxyethylmorpholine (HEM). With no additive, the DEA/HEM ratio was only 2.3, but 2 wt % Na raised this ratio to 10.6. The results are given in Table 2.
The general procedure was repeated except that the liquid flow was 6 mL/hr and the gas flow was 13 mL/min. In one experiment the gas feed was nitrogen. In the other experiment the gas feed contained 5% oxygen. The influence of oxygen concentration in the gas feed on the quantity of various reaction products produced is shown in
The general procedure was repeated using a 5% O2/N gas feed except that the gas flow rate was varied and the reaction was run at 350° C. The influence of gas flow rate on the quantity of the reaction products produced is shown in
The general procedure was repeated except that the liquid flow rate was varied. The influence of liquid feed rate on the quantity of the reaction products produced is shown in
The general procedure was repeated except that the reaction temperature was started at 300° C. and increased to 360° C. slowly. The influence of reaction temperature on the quantity of the products produced is shown in
The general procedure was repeated except that zirconia having three different surface areas were used: high (HSA 98 m2/g), medium (MSA 72 m2/g), and typical surface area (Zr02 52 m2/g). The influence of the surface area of zirconia catalyst on the quantity of the products produced is shown in
A recycle experiment was performed. The feed contained, in area percent, 15.6% MEA, 33.1% TEA, 13.1% DEA, 7.1% HEM, and 4.4% dihydroxyethylpiperazine (DHEP). The recycle feed was charged to the tubular reactor and reacted under the operating conditions of Example 1 except that the residence time was varied. The influence of recycle on the quantity of products produced is shown in
The general procedure of Example 2 was followed except that a 15 wt % aqueous TEA solution was fed at 15 mL/h. The catalyst was a medium surface area zirconia with 10 wt % CeO2. The results are shown in Table 3.
The present non-provisional patent Application claims benefit from U.S. Provisional Patent Application having Ser. No. 61/195,456, filed on Oct. 6, 2008, by Stephen W. King, and titled TRANSALKOXYLATION OF NUCLEOPHILIC COMPOUNDS, wherein the entirety of said provisional patent application is incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
2861995 | MacKenzie | Nov 1958 | A |
3110732 | Speranza et al. | Nov 1963 | A |
3658692 | Gilbert et al. | Apr 1972 | A |
3847754 | Oliver | Nov 1974 | A |
4073750 | Yates et al. | Feb 1978 | A |
4111840 | Best | Sep 1978 | A |
4123462 | Best | Oct 1978 | A |
4209424 | Le Goff et al. | Jun 1980 | A |
4264776 | Hershman et al. | Apr 1981 | A |
4328370 | Fazio | May 1982 | A |
4400539 | Gibson et al. | Aug 1983 | A |
4510263 | Pereira et al. | Apr 1985 | A |
4552961 | Herdle | Nov 1985 | A |
4568746 | Cowherd, III | Feb 1986 | A |
4584405 | Vanderpool | Apr 1986 | A |
4602091 | Brennan | Jul 1986 | A |
4708945 | Murrell et al. | Nov 1987 | A |
4729981 | Kobylinski et al. | Mar 1988 | A |
4801573 | Eri et al. | Jan 1989 | A |
4806517 | Vanderpool et al. | Feb 1989 | A |
4870044 | Kukes et al. | Sep 1989 | A |
4883826 | Marugg et al. | Nov 1989 | A |
4888316 | Gardner et al. | Dec 1989 | A |
4906782 | Hara et al. | Mar 1990 | A |
4922024 | Bowman et al. | May 1990 | A |
4927931 | Molzahn et al. | May 1990 | A |
4983735 | Hartwell et al. | Jan 1991 | A |
5030740 | Bowman et al. | Jul 1991 | A |
5073635 | Bowman et al. | Dec 1991 | A |
5120815 | Marugg et al. | Jun 1992 | A |
5166442 | Hartwell et al. | Nov 1992 | A |
5225599 | King et al. | Jul 1993 | A |
5225600 | King et al. | Jul 1993 | A |
5248827 | Hara et al. | Sep 1993 | A |
5256786 | Bowman et al. | Oct 1993 | A |
5288909 | Hartwell et al. | Feb 1994 | A |
5321160 | Hironaka et al. | Jun 1994 | A |
5352835 | Dai et al. | Oct 1994 | A |
5410087 | Hartwell et al. | Apr 1995 | A |
H1447 | Linton | Jun 1995 | H |
5455352 | Huellmann et al. | Oct 1995 | A |
5552363 | Pannell et al. | Sep 1996 | A |
5554793 | Hartwell et al. | Sep 1996 | A |
5721305 | Eshuis et al. | Feb 1998 | A |
5750790 | King | May 1998 | A |
5851948 | Chuang et al. | Dec 1998 | A |
5935889 | Murrell et al. | Aug 1999 | A |
6117814 | Plecha et al. | Sep 2000 | A |
6124367 | Plecha et al. | Sep 2000 | A |
6169207 | Tsuneki et al. | Jan 2001 | B1 |
6222008 | Gelles | Apr 2001 | B1 |
6235677 | Manzer et al. | May 2001 | B1 |
6306795 | Ryan et al. | Oct 2001 | B1 |
6465530 | Roy-Auberger et al. | Oct 2002 | B2 |
6469214 | Melder et al. | Oct 2002 | B2 |
6534441 | Bartley et al. | Mar 2003 | B1 |
6576796 | Funke et al. | Jun 2003 | B1 |
6703343 | Park | Mar 2004 | B2 |
6977273 | Roy-Auberger et al. | Dec 2005 | B2 |
7045485 | Kelkar et al. | May 2006 | B2 |
7053246 | Gerlach et al. | May 2006 | B2 |
7053247 | Lif et al. | May 2006 | B2 |
7056857 | Srinivasan et al. | Jun 2006 | B2 |
7067455 | Chen et al. | Jun 2006 | B2 |
7256154 | Moon et al. | Aug 2007 | B2 |
7323100 | Espinoza et al. | Jan 2008 | B2 |
7341976 | Espinoza et al. | Mar 2008 | B2 |
7348293 | Timken | Mar 2008 | B2 |
7393978 | Frauenkron et al. | Jul 2008 | B2 |
7541310 | Espinoza et al. | Jun 2009 | B2 |
7595276 | Kodama et al. | Sep 2009 | B2 |
7745369 | Bhan et al. | Jun 2010 | B2 |
7769619 | Krysinski et al. | Aug 2010 | B1 |
7824656 | Idem et al. | Nov 2010 | B2 |
7981836 | Kanazirev et al. | Jul 2011 | B2 |
20030013873 | Neumann et al. | Jan 2003 | A1 |
20050095189 | Brey et al. | May 2005 | A1 |
20060030726 | Telschow | Feb 2006 | A1 |
20070100144 | Frauenkron et al. | May 2007 | A1 |
20080003131 | Bauer et al. | Jan 2008 | A1 |
20100056366 | Lee | Mar 2010 | A1 |
20100087681 | Petraitis et al. | Apr 2010 | A1 |
20100087682 | King et al. | Apr 2010 | A1 |
20100087683 | Cook et al. | Apr 2010 | A1 |
20100087685 | King et al. | Apr 2010 | A1 |
20100094007 | King et al. | Apr 2010 | A1 |
20100094008 | King et al. | Apr 2010 | A1 |
20100137642 | King et al. | Jun 2010 | A1 |
Number | Date | Country |
---|---|---|
0075940 | Apr 1983 | EP |
0163253 | Dec 1985 | EP |
0197611 | Oct 1986 | EP |
0197612 | Oct 1986 | EP |
0254335 | Jan 1988 | EP |
0284398 | Sep 1988 | EP |
0526851 | Feb 1993 | EP |
0737669 | Oct 1996 | EP |
1 211 238 | Jun 2002 | EP |
1211238 | Jun 2002 | EP |
1249440 | Oct 2002 | EP |
1508460 | Apr 1978 | GB |
57019 | Sep 1983 | IL |
2186761 | Aug 2002 | RU |
2226188 | Mar 2004 | RU |
2226189 | Mar 2004 | RU |
WO 9924389 | May 1999 | WO |
0144150 | Jun 2001 | WO |
WO 0166247 | Sep 2001 | WO |
0198243 | Dec 2001 | WO |
WO 03010125 | Feb 2003 | WO |
WO 2005012223 | Feb 2005 | WO |
WO 2005014523 | Feb 2005 | WO |
WO 2005061430 | Jul 2005 | WO |
WO 2006053342 | May 2006 | WO |
WO 2006060206 | Jun 2006 | WO |
WO 2006114417 | Nov 2006 | WO |
WO2007093514 | Aug 2007 | WO |
WO 2008104582 | Sep 2008 | WO |
WO 2009083580 | Jul 2009 | WO |
Number | Date | Country | |
---|---|---|---|
20100087685 A1 | Apr 2010 | US |
Number | Date | Country | |
---|---|---|---|
61195456 | Oct 2008 | US |